# Novo Nordisk a S: Form 6-K, filed May 5, 2026

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 6-K
- Filed: 2026-05-05
- Accepted by EDGAR: May 5, 2026, 09:30 ET
- Period: 2026-05-05
- Accession: 0001171843-26-003010
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000117184326003010/f6k_050526.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000117184326003010/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000117184326003010/f6k_050526.htm

Filed May 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-003010. Last ingested by Listed: Nov 5, 2026, 13:49 ET. No prices; not investment advice.
